Skip to main content
. 2020 Dec 1;15(12):e0243077. doi: 10.1371/journal.pone.0243077

Table 4. Fungal genera exhibiting significant differential abundance (BH corrected P ≤ 0.05) between the gut mycobiomes of Healthy controls (HC, n = 30) and Diabetic Retinopathy (DR, n = 24) individuals.

S. No. Genus Median Abundance (%)* Wilcoxon test—P value (BH corrected P value ≤ 0.05) Pathogenicity
HC DR
Genera decreased in DR
1 Aspergillus 6.116 0.48 0 Human pathogen
2 Issatchenkia 2.387 0.016 0 Plant/Human pathogen
3 Saccharomyces 0.261 0.044 0.045 Non pathogen
4 Kazachstania 0.104 0 0 Not known
5 Didymella 0.011 0 0 Plant pathogen
6 Diutina 0.01 0 0 Human pathogen
7 Rhizopus 0.006 0 0 Plant/Human pathogen
8 Mycosphaerella 0.005 0.001 0.045 Plant pathogen
9 Wickerhamomyces 0.005 0 0 Antimicrobial
10 Gliocladiopsis 0.004 0 0 Plant pathogen
11 Oliveonia 0.004 0 0.045 Not known
12 Cylindrocladiella 0.002 0 0 Plant pathogen
13 Pseudogymnoascus 0.002 0 0 Animal pathogen
14 Backusella 0.001 0 0 Not known
15 Cladorrhinum 0.001 0 0 Human pathogen
16 Corynespora 0.001 0 0 Plant pathogen
17 Vishniacozyma 0.001 0 0 Antimicrobial
18 Volutella 0.001 0 0.045 Plant pathogen

*Differentially abundant genera having a median abundance ≥ 0.001% in at least one group of samples are listed.

P value of 0 indicates ≤ 0.0001.